Bill Text: CT SB00396 | 2011 | General Assembly | Comm Sub
Bill Title: An Act Concerning Insurance Coverage For The Screening And Treatment Of Prostate Cancer And Prohibiting Differential Payment Rates To Health Care Providers For Colonoscopy Or Endoscopic Services Based On Site Of Service.
Spectrum: Moderate Partisan Bill (Democrat 18-1-1)
Status: (Passed) 2011-07-13 - Signed by the Governor [SB00396 Detail]
Download: Connecticut-2011-SB00396-Comm_Sub.html
General Assembly |
||
January Session, 2011 |
*_____SB00396INS___022311____* |
AN ACT CONCERNING INSURANCE COVERAGE FOR THE SCREENING AND TREATMENT OF PROSTATE CANCER.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. Section 38a-492g of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2012):
[Each] On and after January 1, 2012, and until December 31, 2013, each individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state [on or after January 1, 2000,] shall provide coverage for: [laboratory]
(1) Laboratory and diagnostic tests, including, but not limited to, prostate specific antigen (PSA) tests, to screen for prostate cancer for men who are symptomatic [,] or whose biological father or brother has been diagnosed with prostate cancer, and for all men fifty years of age or older; [.] and
(2) The treatment of prostate cancer, provided such treatment is medically necessary and in accordance with guidelines established by the National Comprehensive Cancer Network, the American Cancer Society or the American Society of Clinical Oncology.
Sec. 2. Section 38a-518g of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2012):
[Each] On and after January 1, 2012, and until December 31, 2013, each group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state [on or after January 1, 2000,] shall provide coverage for: [laboratory]
(1) Laboratory and diagnostic tests, including, but not limited to, prostate specific antigen (PSA) tests, to screen for prostate cancer for men who are symptomatic [,] or whose biological father or brother has been diagnosed with prostate cancer, and for all men fifty years of age or older; [.] and
(2) The treatment of prostate cancer, provided such treatment is medically necessary and in accordance with guidelines established by the National Comprehensive Cancer Network, the American Cancer Society or the American Society of Clinical Oncology.
This act shall take effect as follows and shall amend the following sections: | ||
Section 1 |
January 1, 2012 |
38a-492g |
Sec. 2 |
January 1, 2012 |
38a-518g |
INS |
Joint Favorable Subst. |